18-121
Showing 1 - 25 of >10,000
Hemophilia A, Hemophilia B Trial in Worldwide (Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US), Haemophilia
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)
- Haemophilia Joint Health Score (HJHS)
-
Sofia, Bulgaria
- +55 more
May 3, 2023
Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Recruiting
- Systemic Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +65 more
Jan 18, 2023
Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Completed
- Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +85 more
Sep 8, 2022
Mucopolysaccharidosis Type II (MPS II) Trial in Oakland, Montréal (RGX-121)
Recruiting
- Mucopolysaccharidosis Type II (MPS II)
- RGX-121
-
Oakland, California
- +1 more
Oct 6, 2022
Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib)
Recruiting
- Juvenile Idiopathic Arthritis
-
Rosario, Santa Fe, Argentina
- +95 more
Jan 18, 2023
Acne Trial in United States (IDP-121 Lotion, IDP-121 Vehicle Lotion)
Completed
- Acne
- IDP-121 Lotion
- IDP-121 Vehicle Lotion
-
Guntersville, Alabama
- +38 more
Dec 16, 2019
Acne Trial in United States (IDP 121 Lotion, IDP-121 Vehicle Lotion)
Completed
- Acne
- IDP 121 Lotion
- IDP-121 Vehicle Lotion
-
Glendale, Arizona
- +33 more
Dec 16, 2019
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)
Active, not recruiting
- Metastatic Breast Cancer
- PARP inhibitor 2X-121
-
Herlev, Denmark
- +1 more
Feb 1, 2023
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Mucopolysaccharidosis Type II (MPS II) Trial in Brazil, United States (RGX-121)
Recruiting
- Mucopolysaccharidosis Type II (MPS II)
- RGX-121
-
Oakland, California
- +4 more
Dec 22, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)
Active, not recruiting
- Cystic Fibrosis
- VX-121/TEZ/D-IVA
- +5 more
-
Birmingham, Alabama
- +169 more
Dec 22, 2022
Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)
Recruiting
- Advanced Solid Tumors
- 2X-121 and dovitinib
-
Huntersville, North Carolina
- +1 more
Feb 1, 2023
ADHD Trial in United States (Amphetamine Sulfate, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- Amphetamine Sulfate
- Placebo
-
Encino, California
- +30 more
Oct 20, 2020
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
Oral HPV Infection in Patients Who Are Positive to the PAP-test
Recruiting
- HPV Infection
-
Catania, ItalyAOU Policlinico G. Rodolico
Jul 13, 2023